CBUS
Cibus Global LLC
NASDAQ: CBUS · HEALTHCARE · BIOTECHNOLOGY
$1.40
+9.37% today
Updated 2026-04-30
Market cap
$114.42M
P/E ratio
—
P/S ratio
31.44x
EPS (TTM)
$-2.78
Dividend yield
—
52W range
$1 – $4
Volume
0.7M
Cibus Global LLC (CBUS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $26.00M | $16.62M | $72.17M | $118.79M | $88.10M | $63.33M | $37.19M | $22.42M | $544.41M | $350.07M |
| Cash & equivalents | $24.69M | $5.03M | $56.66M | $93.79M | $58.61M | $17.30M | $13.82M | $3.43M | $32.70M | $14.43M |
| Current assets | $25.03M | $5.46M | $57.46M | $95.52M | $63.52M | $39.59M | $15.18M | $4.13M | $35.22M | $16.95M |
| Total liabilities | $1.74M | $3.50M | $14.69M | $25.39M | $25.59M | $26.45M | $23.06M | $15.19M | $206.12M | $252.24M |
| Current liabilities | $1.04M | $2.87M | $4.25M | $7.00M | $7.20M | $6.95M | $4.85M | $1.66M | $21.32M | $19.88M |
| Long-term debt | — | $521000.00 | $190000.00 | — | — | $1.52M | — | — | $536000.00 | $226000.00 |
| Shareholder equity | $24.26M | $13.12M | $57.48M | $93.40M | $62.51M | $36.88M | $14.13M | $7.23M | $293.47M | $92.16M |
| Retained earnings | $-16.48M | $-28.57M | $-54.55M | $-82.44M | $-122.06M | $-166.89M | $-196.09M | $-212.15M | $-479.78M | $-731.17M |
| Accounts receivable | $334000.00 | $157000.00 | $167000.00 | $46000.00 | $1.12M | $4.89M | $0.00 | $0.00 | $530000.00 | $1.04M |
| Inventory | — | $798000.00 | $1.26M | $1.31M | $2.59M | $1.38M | $0.00 | — | — | — |
| Goodwill | — | — | — | — | — | — | — | $0.00 | $434.90M | $253.47M |